-
News | 2022.03.22
Ukrainian scientists: offer to join a host laboratory at the Institut Pasteur in Paris
In view of the ongoing war in Ukraine, the Institut Pasteur is providing funding to host Ukrainian scientists in its research laboratories.
-
Document de presse | 2022.07.21
SARS-CoV-2 hijacks nanotubes between neurons to infect them
COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both during the acute phase of the disease and over the long term with "long COVID" syndrome. But the way in which the infection reaches the brain was previously unknown. Scientists from Institut Pasteur and CNRS laboratories have used...
-
News | 2023.02.28
Health crises, information crises: exploring the roots of the term "infodemic"
How do the epidemiological and media dimensions of a health crisis fit together? How is the spread of a virus linked to the spread of information about it? Several scientists, communication experts and ethics specialists came together to explore these questions at a conference held at the Institut Pasteur in December.
-
Document de presse | 2022.03.29
SARS-CoV-2: neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies
The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of COVID-19. Several monoclonal antibodies are currently available in clinical practice as a preventive treatment for these patients....
-
News | 2023.02.22
Collaboration with UCSF QBI: Institut Pasteur establishes presence in USA
A delegation from the Institut Pasteur will visit San Francisco during the week of February 28 to March 2, 2023, to present a series of events and workshops that will provide an overview of the Institut Pasteur-UCSF QBI partnership (Institut Pasteur-University of California, San Francisco, Quantitative Biosciences Institute). These events will also promote the establishment of a Center of...
-
News | 2024.07.04
How coronavirus HKU1 forces its way into cells
Scientists have pinpointed the precise binding sites for the virus HKU1 in respiratory cells, providing a detailed picture of the infection mechanism used by the virus. Their findings shed light on other animal species that may host the virus and pave the way for the development of infection-blocking antibodies.
-
News | 2021.02.08
Antibiotic response in bacteria: the role of membrane vesicles
Membrane vesicles (also known as extracellular vesicles) are produced by all kinds of organisms. They are small lipid bags that come off a donor cell and get internalized by a recipient cell. Their role is to carry biological information and they are described as key intercellular communication players. However, their role in the microbial world is still very much unknown. Researchers from the...
-
News | 2021.03.03
Primary Immunodeficiencies: launch of the second phase of the ATun-DIP's project in the North-Western regions of Tunisia
After more than three years of activities in the underprivileged regions of the Centre and South of Tunisia, the second phase of the ATun-DIP's project (Improvement of the management of Tunisian children suffering from Primary Immunodeficiency Diseases) started on February the 4th, 2021. The project, coordinated by the Institut Pasteur de Tunis in collaboration with several partners including the...
-
Document de presse | 2021.04.23
Professor Stewart Cole appointed Institut Pasteur President for a further two-year term
On Friday April 16, the Institut Pasteur Board of Governors appointed Professor Stewart Cole President for a further two-year term from January 1, 2022 to December 31, 2023.This decision is based on the President's commitment to the development and implementation of the 2019-2023 Strategic Plan, which includes the key priority of tackling infectious diseases, and on his ability to carry out the...
-
Document de presse | 2021.10.11
SARS-CoV-2 Alpha, Beta and Delta variants display enhanced viral fusion properties compared to ancestral strains
In a new study published in EMBO Journal on October 2, 2021, scientists from the Institut Pasteur, the CNRS, Université de Paris, the Vaccine Research Institute and Sorbonne University examined the fusion mechanisms of different SARS-CoV-2 variants: Alpha (initially identified in the United Kingdom), Beta (initially identified in South Africa) and Delta (initially identified in India). The Delta...
